Effect of Serum Fibrinogen, Total Stent Length, and Type of Acute Coronary Syndrome on 6-Month Major Adverse Cardiovascular Events and Bleeding After Percutaneous Coronary Intervention
Ehtisham Mahmud(Cardiovascular Institute of the South), Lawrence Ang(University of California San Diego), Mattheus Ramsis(University of California San Diego), Ryan Reeves(University of California San Diego), Omid Behnamfar, Shiqian Li(Sichuan University), Felice Lin(Centers for Disease Control and Prevention), Andrew Huynh(University of California San Diego), Kelly Enright(University of California San Diego), Mitul Patel(University of California San Diego), Phildrich Teh(University of California San Diego), Khushboo Kaushal(University of California San Diego), Samhita Palakodeti(University of California San Diego)
Cited by 21
Related Papers
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
|Journal of the American College of Cardiology|2020|415
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
|Journal of the American College of Cardiology|2020|395
Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant <i>Staphylococcus aureus</i> Clone USA300 in Men Who Have Sex with Men
|Annals of Internal Medicine|2008|391